drugset / Trial / NCT04576312

Safety of Ascending Doses of Niclosamide (UNI911 INHALATION) in Healthy Volunteers

NCT04576312

Phase 1 Completed 64 enrolled UNION therapeutics
RandomizedSequentialQuadruple-blindOther

Summary

This is a Phase 1 Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess the Safety of Ascending Doses of UNI911 INHALATION in Healthy Volunteers in Preparation for Evaluation in Adults with COVID-19

Timeline

Start
2020-06-29
Primary completion
2020-12-04
Completion
2020-12-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Niclosamide Unknown 2.5 mg Inhaled
Subject Niclosamide Unknown 3.4 mg Inhaled
Subject Niclosamide Unknown 8.4 mg Inhaled
Subject Niclosamide Unknown 25.2 mg Inhaled
Subject Niclosamide Unknown 50.4 mg Inhaled

Indications